We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.
We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.
Emesa Foods Issues Recall of Premium Sesame Tahini Due to Possible Salmonella
Emesa Foods has issued a voluntary recall of 800-gram Premium Sesame Tahini due to the potential to be contaminated with Salmonella.
Affected products were distributed in Michigan and Texas, in 28.2 oz containers. Expiration dates of 2/25/2021 are printed on the sides of the containers.
The problem was discovered during routine random sampling by the Michigan Department of Agriculture and Rural Development. No adverse events have been reported to date.
Read the recall statement
Almark Foods Issues Recall of Hard-Boiled Eggs From Gainesville, Georgia, Due to Possible Listeria monocytogenes
Almark Foods has issued a voluntary recall of all hard-boiled eggs manufactured at the firm’s Gainesville, Georgia, facility due to potential contamination with Listeria monocytogenes.
The problem was discovered after the FDA notified Almark Foods that the products may be related to a Listeria monocytogenes outbreak that has been linked to several illnesses and 1 death.
Read the full
Mavidon Issues Recall of All Manufactured Products Due to Possible Burkholderia cepacia Contamination
Mavidon has issued a voluntary recall of all products manufactured at the firm’s facility including LemonPrep, PediaPrep, and Wave Prep 4-ounce tubes and single use cups, Cardio Prep and Collodions due to contamination with Burkholderia cepacia.
The problem was discovered during an FDA inspection, which identified Burkholderia cepacia in samples of 114gm tubes of Lemon Prep.
Hospitals and clinics with any Mavidon products should immediately stop using the products and quarantine them. Burkholderia cepacia is a multidrug-resistant pathogen, and contamination can result in life-threatening infections for patients with compromised immune systems.
To date, Mavidon has received reports of 1 adverse event associated with the recalled products.
Read the
